For its fourth fiscal quarter (ending March 31), Steris Plc (NYSE: STE) has reported a -18% decline in E.P.S. from $1.89 a year ago to $1.55 in the current quarter. This performance was $-0.83 short of the consensus estimate of $2.38. E.P.S. were $5.58 for the latest four quarters through March 31 versus $1.07 for the same period a year ago — an increase of 421%.
Recent Price Action
On 5/8/24, Steris Plc (NYSE: STE) stock declined modestly by -1.3%, closing at $210.09. Moreover, this decline was accompanied by unusually high trading volume at 184% of normal. The stock has risen 2.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
STE is expected to continue to be an important Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Steris has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Steris has a neutral Appreciation Score of 51 but a poor Power Rating of 30, resulting in the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment